Enhanced Safety Aesthetic Laser System
Recruitment status was Not yet recruiting
The purpose of this study is to determine whether a new laser system provides better safety and efficacy than existing lasers in popular cosmetic procedures such as hair removal, treatment of cosmetically disturbing vascular lesions and rhytides.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
|Official Title:||Peterio™ – an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments|
- Hair, vascular lesions and wrinkles reduction as counted 1-3 months after each treatment session, depending on the treated area.
- Measuring treatment discomfort as graded by the patients
|Study Start Date:||September 2007|
|Estimated Study Completion Date:||September 2008|
Cosmetic lasers are a well-established, popular modality for removal of unwanted hair, treatment of all types of vascular lesions, including hemangiomas, port wine stains, and a variety of telangiectases as well as facial rhytides reduction. The existing lasers are based on a wavelength that is specifically absorbed by the chromophore found in the target such as hair follicle, where the energy is converted to heat resulting in a thermal injury. However, the lasers for cosmetic treatments are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. Similar problem exists when targeting other chromophores such as hemoglobin or water. The purpose of the study is an evaluation of safety and efficacy of a new laser based device.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00495443
|Contact: Alex Rapoport, BSCfirstname.lastname@example.org|
|Hadassah Medical Center, Dermatology||Not yet recruiting|
|Jerusalem, Israel, 91120|
|Principal Investigator: Leon Gilad, MD|
|Principal Investigator:||Leon Gilad, MD||Hadassah Medical Center, Dermatology|